Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV May 7, 2019
Protenus 2019 Drug Diversion Digest: 47.2 Million Doses Lost Due to Hospital Employee Theft and Misuse May 7, 2019
Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting April 29, 2019
Orchard Therapeutics Strengthens Commercial Leadership Team with Appointment of Francis Pang as Vice President of Global Market Access April 26, 2019
Orchard Therapeutics Announces First Patient Dosed with Cryopreserved Formulation of OTL-103 Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome April 25, 2019
Acacia Pharma Announces Positive Phase 3 Barhemsys® Rescue Treatment Data To Be Presented At The Annual Congress Of Enhanced Recovery And Perioperative Medicine April 25, 2019